2 completed, 1 not yet recruiting. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 2 | 2 | Completed 1, Not yet recruiting 1 |
Follow Osteogenesis imperfecta, type 3: new trials by email Literature Review of Osteogenesis imperfecta, type 3 trials Research Report on Osteogenesis imperfecta, type 3
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mesenchymal Cell Therapy in Osteogenesis Imperfecta (OI) Bone marrow-derived mesenchymal stromal cells (MSCs) - Osteogenesis Imperfecta, Osteogenesis Imperfecta Type III | Phase 1 / Phase 2 | Not yet recruiting | Emory University | 12 | 2027-01-01 | 2026-05-08 |
| A Study in Adult Patients With Type I, III or IV Osteogenesis Imperfecta Treated With BPS804 setrusumab, Calcium, Vitamin D - Osteogenesis Imperfecta, Type I, Osteogenesis Imperfecta Type III | Phase 2 | Completed | Ultragenyx Pharmaceutical Inc | 112 | 2017-09-11 | 2023-07-05 |
| Repeated Infusions of Mesenchymal Stromal Cells in Children With Osteogenesis Imperfecta Mesenchymal Stromal Cells - Osteogenesis Imperfecta Type II, Osteogenesis Imperfecta Type III | Phase 1 | Completed | Nationwide Children's Hospital | 5 | 2010-02-01 | 2015-04-24 |
Bone Diseases (3) · Bone Diseases, Developmental (3) · Collagen Diseases (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Connective Tissue Diseases (3) · Genetic Diseases, Inborn (3) · Musculoskeletal Diseases (3) · Osteochondrodysplasias (3) · Skin and Connective Tissue Diseases (3)
Calcium (1) · Vitamin D (1) · Zoledronic Acid (1) · setrusumab (1)
Emory University (1) · Nationwide Children's Hospital (1) · Ultragenyx Pharmaceutical Inc (1)
United States (2) · Canada (1) · Denmark (1) · France (1) · United Kingdom (1)
Alix Seif, MD (1) · Doris Fadoju, MD (1)
2016 (1)